La transcription bactérienne est un processus dans lequel l'information codée dans l'ADN est transféré à l'ARN messager (ARNm). Au cours de la dernière étape de ce procédé, la terminaison de la transcription, l'ARNm est libéré et peut être utilisé pour la synthèse des protéines. Un type de terminaison de la transcription décrit chez les bactéries est la terminaison Rho-dépendante. Le rôle de Rho a été largement étudié dans le modèle à Gram négatif bactérie, Escherichia coli dans laquelle Rho est une protéine essentiel est abondant. En revanche, la connaissance de Rho chez les bactéries qui il ne sont pas essentiels et est présent en faibles quantités: par exemple Gram-positif Bacillus subtilis reste limité..Pour étudier le rôle de Rho dans le contrôle de l'expression des gènes chez B. subtilis plusieurs analyses à grande échelle ont été réalisées, y compris des tests d'interactions physiques et fonctionnelles et une analyse globale des changements observés dans l'expression des gènes en corrélation avec la production de protéines.En effet, un ensemble des Rho-spécifiques interactions physiques et fonctionnelles ont été établies. En outre, de nouveaux phénotypes de mutant dépourvu de rho ont été décrits ce qui élucider le rôle de Rho dans le contrôle des différents aspects de la physiologie cellulaire. / Bacterial transcription is a process in which the information encoded in DNA is transferred to messenger RNA (mRNA). During the final step of this process, transcription termination, mRNA is released and can be used for protein synthesis. One type of transcription termination described in bacteria is Rho-dependent termination. The role of Rho has been widely investigated in model Gram-negative bacterium, Escherichia coli in which Rho is essential an abundant protein. In contrast, the knowledge about Rho inbacteria in which it is not essential and is present in low amounts, i. e. Gram-positive Bacillus subtilis remains limited.To investigate the role of Rho in control of gene expression in B. subtilis several large-scale analysis were performed. In effect, a set of Rho-specific physical and functional interactions were established. Additionally, new phenotypes of rho-null mutant were described unraveling the role of Rho in control of different aspects of cell physiology.

La progression métastatique des cancers est responsable de 90% des décès liés à la maladie. Cette cascade est initiée par l’invasion des cellules cancéreuses du stroma péritumoral, et conduit à leur dissémination dans l’organisme.Mon travail de thèse a eu pour but d’identifier les mécanismes moléculaires et cellulaires régulant l’invasion des cancers colorectaux (CRC), qui est le 2ème cancer le plus répandu dans le monde. Grâce à une analyse réalisée sur des échantillons humains de tumeurs primaires, nous avons révélés que les cellules de CRC utilisent un mode d’invasion collective dans lequel elles gardent une architecture glandulaire spécifique des épithelia. Afin d’étudier les voies de signalisation régulant cette invasion, nous avons utilisé des modèles organotypiques récapitulant l’architecture des glandes de CRC (cystes de Caco-2 et tumoroïdes de xénogreffes derivés de patients) dans des tests d’invasion utilisant du collagen-I. Du fait de son rôle central dans la régulation de la motilité cellulaire, la voie des RhoGTPases était un bon candidat à la régulation de l’invasion collective des CRC. Dans un screen utilisant des siRNA ciblant tous les effecteurs connus des RhoGTPases, seule la déplétion des protéines kinases ROCK a déclenché l’invasion collective dans notre système expérimental. Nous avons démontré que l’inhibition de ROCK2 et non de ROCK1 était suffisante pour induire la formation de cellules leader, permettant la polarisation leader/follower requise pour l’invasion collective. Nos résultats montrent que l’inhibition de ROCK2 déclenche l’invasion collective par l’inhibition de MyosinII combinée à l’activation du facteur d’échange nucléotide guanine (GEF), FARP2, et de RAC1. Notre étude permet donc d’identifier FARP2 comme un nouvel effecteur de ROCK2 et le positionne comme un nouveau médiateur du crosstalk entre RhoA et RAC1 dans la régulation de l’invasion collective des CRC. En conclusion, nous avons décrit une nouvelle voie de signalisation dépendante de ROCK2 contrôlant l’invasion collective de glandes de CRC. De façon intéressante, notre étude révèle un rôle anti-invasive de ROCK2 contredisant son rôle pro-invasive décrit dans l’invasion de cellules individuelles. Cela suggère que ROCK2 assure des rôles distincts en fonction du mode d’invasion adopté par les cellules cancéreuses et remet en question le bénéfice thérapeutique de l’inhibition de ROCK proposé pour bloquer l’invasion des cellules cancéreuses. / Metastatic progression of cancer is responsible for 90% of the disease related death. It is a multi-step process which is initiated by invasion of the peritumoral stroma by cancer cells and which leads to the dissemination of cancer cells in the organism.My PhD work aimed at identifying the molecular and cellular process driving colorectal carcinoma (CRC) invasion, which is the 2nd most frequent cancer worldwide. Our analysis of live and human primary cancer specimen revealed that CRC cells used a collective mode of invasion to disseminate, in which cells retain an epithelium specific -glandular architecture. To investigate the signaling pathways regulating this mode of invasion, we used 3D organotypic models recapitulating the features of CRC glands (Caco-2 cysts and Patient derived Xenografts (PDX) tumoroids) in collagen-I based organotypic invasion assays and in microscopy-based analyses. Because of its central role in the regulation of cell motility, we postulated that RhoGTPases signaling pathways could control the collective of CRC. In a siRNA based- screen targeting all the known effectors of RhoGTPases we found that only ROCK kinases downregulation induced collective invasion in our experimental settings. We demonstrated that ROCK2 but not ROCK1 inhibition was sufficient to promote Leader cell formation, which induced the leader/follower polarization necessary for collective invasion. Our results revealed that ROCK2 inhibition triggered collective invasion through the concomitant inhibition of MyosinII and activation of the guanine nucleotide exchange factor (GEF) FARP2 and the RhoGTPase RAC1. We therefore identify FARP2 as a new effector of ROCK2 and a mediator of the RhoA-RAC1 crosstalk in the regulation of collective invasion. In conclusion our study proposes a new ROCK dependent-signaling pathway in the regulation of collective invasion of highly polarized CRC glands models. Importantly, we found ROCK2 to be an anti-invasive protein which is in contradiction with its described pro-invasive role in single cell invasion. This suggests distinct roles of ROCK which may depend on the mode of invasion adopted by the cells and questions the benefice of proposed ROCK inhibition strategies to block cancer cell invasion.

Indiana University-Purdue University Indianapolis (IUPUI) / Knowledge of the molecular and cellular mechanisms of ischemic injury is necessary for understanding acute kidney injury and devising optimal treatment regimens. The cortical actin cytoskeleton in the proximal tubule epithelial cells of the kidney nephron, playing an important role in both the establishment and maintenance of cell polarity, is drastically disrupted by the onset of ischemia. We found that in LLC-PK cells (a porcine kidney proximal tubule epithelial cell line), cortactin, an important regulator of actin assembly and organization, translocated from the cell cortex to the cytoplasmic regions upon ischemia/ATP-depletion. Meanwhile both the tyrosine phosphorylation level of cortactin and cortactin’s interaction with either F-actin or the actin nucleator Arp2/3 complex were down-regulated upon ischemia/ATP-depletion or inhibition of Src kinase activity. These results suggest that tyrosine phosphorylation plays an important role in regulating cortactin’s cellular function and localization in the scenario of kidney ischemia. The Rho GTPase signaling pathways is also a critical mediator of the effects of ATP depletion and ischemia on the actin cytoskeleton, but the mechanism by which ATP depletion leads to altered RhoA and Rac1 activity is unknown. We propose that ischemia and ATP depletion result in activation of AMP-activated protein kinase (AMPK) and that this affects Rho GTPase activity and cytoskeletal organization (possibly via TSC1/2 complex and/or mTOR complex). We found that AMPK was rapidly activated (≤5 minutes) by ATP depletion in S3 epithelial cells derived from the proximal tubule in mouse kidney, and there was a corresponding decrease in RhoA and Rac1 activity. During graded ATP-depletion, we found intermediate levels of AMPK activity at the intermediate ATP levels, and that the activity of RhoA and Rac1 activity correlated inversely with the activity of AMPK. Activation of AMPK using two different drugs suppressed RhoA activity, and also led to morphological changes of stress fibers. In addition, the inhibition of AMPK activation partially rescued the disruption of stress fibers caused by ATP-depletion. This evidence supports our hypothesis that the activation of AMPK is upstream of the signaling pathways that eventually lead to RhoA inactivation and cytoskeletal dysregulation during ATP-depletion.

No description available.

Rho-GTPases are essential signalling proteins which regulate a multitude of central cellular processes that are vital for organisms to thrive and adapt to changing environments. Many regulatory networks involving Rho proteins have first been elucidated in the model yeast Saccharomyces cerevisiae, in which Rho5 emerges as a central hub connecting different signalling pathways, such as the responses to cell wall stress, high medium osmolarity, and oxidative stress. In this work, the rapid translocation of Rho5 to mitochondria as reaction to oxidants and glucose starvation was thoroughly investigated. The studies on structure-function relationships was focussed on the C-terminal region of the Rho5 which in other Rho-type GTPases determines their spatio-temporal distribution and contributes to their physiological function. The C-terminal end of these GTPases is considered to be a hypervariable region (HPR) that consists of a polybasic region (PBR) and its preceding amino acid residues, followed by the CAAX motif which becomes prenylated at its cysteine residue. These motifs are conserved in the yeast Rho5 where the PBR contains a serine residue as a putative phosphorylation target. Moreover, Rho5 of S. cerevisiae is characterized by an extension preceding the PBR that comprises 98 amino acid residues. While substitutions of the serine residue within the PBR for either phosphomimetic or non-phosphorylatable residues indicate that it is of minor physiological importance, deletion analyses of the yeast-specific extension showed that it is required for proper localization of Rho5 to the plasma membrane. As expected, substitution of the cysteine residue within the CAAX motif also prevented proper plasma membrane localization, accompanied by a loss of function both with respect to oxidative stress response and glucose starvation. Results from studies employing a trapping-device of GFP-Rho5 to the mitochondrial surface indicate that the GTPase needs to be activated at the plasma membrane by its dimeric GDP/GTP exchange factor (GEF) which is composed of Dck1 and Lmo1, in response to stress conditions. The trimeric DLR complex is then capable of rapidly translocate to mitochondria and fulfil its functions at the organelle. This view was supported by the finding that a constitutively active Rho5 variant restored function when trapped to mitochondria. Interestingly, Rho5 requires the dimeric GEF for the translocation process under oxidative stress while Dck1 and Lmo1 can reach the mitochondria independent from each other. Finally, the human Rho5 homolog Rac1 cannot complement the defects of a rho5 deletion and does not show a proper intracellular distribution, unless its C-terminal end is equipped with the yeast-specific extension. Taken together, the results of this thesis contributed to a better understanding of the structure-function relationships of Rho5 and its human homolog Rac1.

No description available.

Thèse numérisée par la Direction des bibliothèques de l'Université de Montréal.

Die Stabiltät und Integrität der Epidermis beruht zu einem großen Teil auf der intakten Funktion der Desmosomen. Diese fleckförmigen Zellkontakte vermitteln extrazellulär die Haftung zwischen den Keratinozyten durch Desmocadherine und sind intrazellulär über Adaptorproteine im Intermediärfilamentsystem des Zellskeletts verankert. Diese Funktion ist bei der Autoimmunerkrankung Pemphigus gestört, die zu intraepidermaler Blasenbildung durch Akantholyse der Keratinozyten führt. Pemphigus vulgaris (PV) und Pemphigus foliaceus (PF) stellen die beiden Hauptvarianten dar, wobei PV durch Autoantikörper gegen die Desmocadherine Desmoglein (Dsg) 3 und oftmals zusätzlich gegen Dsg 1, PF durch Autoantikörper nur gegen Dsg 1 gekennzeichnet ist. Rho-GTPasen sind zelluläre Regulatorproteine, die das Aktinzytoskelett und verschiedene Zellkontakte beeinflussen. Die vorliegende Arbeit beschäftigte sich mit dem Einfluss von Rho-GTPasen bei der Regulation von desmosomal vermittelter Adhäsion. In einem zweiten Teil wurde die Beteiligung von Rho-GTPasen bei den Pemphigusvarianten PV und PF näher charakterisiert. Für den ersten Abschnitt wurden bakterielle Toxine verwendet, die spezifisch Rho GTPasen aktivieren bzw. inhibieren, während für den zweiten Teil IgG-Fraktionen von PV- und PF-Patienten in Kombination mit aktivierenden Toxinen zur Anwendung kamen. Eine Inhibition der drei Hauptvertreter der Rho-GTPasen in kultivierten Keratinozyten und humaner Epidermis führte zu einer Rarefizierung des Aktinfilamentsystems, zu Verlust von membranständig lokalisiertem Dsg 1 und 3 und zu Zelldissoziation sowie zu verminderter Dsg 1 und 3-vermittelter Haftung von Mikroperlen auf der Oberfläche von Keratinozyten. Die Aktivierung der GTPasen resultierte in vermehrter linearisierter Darstellbarkeit von Aktin und Dsg 3 an den Zellgrenzen und einer verstärkten Dsg-vermittelten Haftung. Pemphigus-IgG führten ebenfalls zu Zelldissoziation und Verlust von Dsg-Immunreaktivität in Keratinozytenkulturen, zu Spaltbildung in humaner Epidermis und zum Verlust der durch Dsg 1 und Dsg 3 vermittelten Adhäsion. Dies ging einher mit einer vermehrten Menge an nicht am Zytoskelett verankerten Dsg 3 und wurde durch eine p38MAPK-abhängige Verminderung der Aktivität von Rho A moduliert. Die Aktivierung von Rho A verhinderte die Ausbildung der Pemphigus-induzierten Effekte nahezu vollständig. Zusammenfassend regulieren Rho-GTPasen die desmosomale Haftung in Keratinozyten. Die Daten zeigen weiterhin, dass Pemphigus-IgG durch eine Inhibition von Rho A diese Regulation beeinträchtigt, was zu Schwächung der Zytoskelettverankerung von Desmogleinen und zu Haftungsverlust und Spaltbildung führt. Somit ist Rho A ein wichtiger Faktor der Pemphigus-Pathogenese und stellt einen Erfolg versprechenden Ansatzpunkt zur Entwicklung neuer Therapieoptionen dar. / Integrity and stability of human epidermis is based on the correct function of desmosomes. These spot-like cell contacts mediate adhesion of adjacent keratinocytes by desmosomal cadherins and are linked via adapter proteins to the intermediate filament cytoskeleton. This function is impaired in the autoimmune disease pemphigus, resulting in intraepidermal blister formation by akantholysis of keratinocytes. Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are the main subtypes of pemphigus, with PV being characterized by autoantibodies targeting the desmosomal cadherins Desmoglein (Dsg) 3 and in part Dsg1. PF patients develeop autoantibodies against Dsg1 only. Rho GTPases are regulatory proteins which are known to modulate the actin cytoskeleton and different cell contacts. The aim of this thesis was to evaluate the role of Rho GTPases in the regulation of desmosome-mediated adhesion. The second part addresses the involvement of Rho GTPases in the pathogenesis of PV and PF. Toxins served to activate or inactivate specific GTPases in the first part, whereas in the latter part purified IgG fractions of pemphigus patients were used in combination with Rho activating toxins. An inhibition of the three best characterized GTPases in cultured keratinocytes and human epidermis resulted in rarefication of the actin cytoskeleton, loss and fragmentation of membrane-localized Dsg1 and Dsg3 immunostaining, cell dissociation and reduced adhesion of Dsg1 and Dsg3-coated microbeads on the cell surface of keratinocytes. Activation of GTPases led to linearized immunoreactivity of Dsg3 at the cell membrane, pronounced cortical actin staining and strengthened Dsg-mediated adhesion. Similarily to inhibition of Rho-GTPases, Pemphigus IgG caused cell dissociation and loss of Dsg staining in cultured keratinocytes, blister formation in human epidermis and reduction of Dsg-mediated adhesion. These changes were accompanied by a decrease of cytoskeleton-bound Dsg3 and were modulated by a p38MAPK-dependent reduction of RhoA activity. Activation of RhoA blocked the Pemphigus IgG-induced effects. Taken together, Rho GTPases regulate desmosomal adhesion in keratinocytes. Additionaly, Pemphigus IgG interfere with this regulation by inhibition of RhoA, resulting in reduced cytoskeletal anchorage of desmogleins, reduced intercellular adhesion and gap formation. Thus RhoA is identified as an important factor in pemphigus pathogenesis and might eventually serve as a target of new therapy approaches.

Furthermore, ACS patients with a high N-terminal pro-B-type natriuretic peptide (NT-proBNP) and a high ROCK activity on admission had a five-fold risk to experience a cardiovascular event, when compared to those with low NT-proBNP and low ROCK activity. In addition, patients with high NT-proBNP and high ROCK activity were also more likely to die or experience a cardiovascular event at two years when comparing to those with high NT-proBNP and low ROCK activity. / In both ACS and CHF study cohorts, all the clinical parameters were recorded and analyzed. / In the first part of this thesis, 176 ACS patients and 51 control subjects were studied. All The patients were enrolled between December 2007 and May 2009 and followed up till 15th March 2010 (mean: 15.4+/-7.6 months, from 0.5 month to 27.5 months). The main outcome measures were all cause mortality, readmission with ACS or congestive heart failure (CHF) at 2 years from presentation. Altogether, there were 23 deaths (13.1%),33 readmissions with ACS (18.8%) and 13 admissions with CHF (7.4%) within 2 years. / Recent studies have shown that ROCK may playa pivotal role in cardiovascular diseases such as vasospastic angina, ischemic stroke, heart failure and metabolic syndrome via its involvement in regulation of vascular tone, endothelial dysfunction, inflammation, and remodeling. Indeed, inhibition of ROCK by statins or other selective inhibitors leads to upregulation and activation of endothelial nitric oxide synthase (eNOS) and reduction of vascular inflammation and atherosclerosis. In this thesis, we hypothesized that ROCK activity is increased in a selected population of patients with acute coronary syndrome (ACS) and congestive heart failure (CHF) and that ROCK activity is able to predict long-term clinical outcomes in these two populations. / Rho/rho-kinase (ROCK) is a serine-threonine protein kinase, which is one of the first immediate downstream targets of RhoA and expressed ubiquitously. ROCK is involved in many cellular functions, such as, cell growth, migration, apoptosis via actin cytoskeleton organization, and gene expression. They regulate cell contraction through serine-threonine phosphorylation of adducin, ezrin-radixin-moesin proteins, LIM kinase, myosin light chain phosphatase, and Sodium-Hydrogen ion (Na/H) exchanger. / The main findings are: ROCK activity was increased in ST elevation myocardial infarction (STEMI), non-STEMI (NSTEMI) and unstable angina (UA) groups when comparing with disease controls and healthy controls. On multivariate analysis, heart failure symptom on presentation, LDL-C level, and number of diseased coronary vessels were independent predictors of ROCK activity in ACS patients. / The ROCK activity in CHF patients was significantly higher than that of the disease control and normal control groups. New York Heart Association (NYHA) class, low left ventricular ejection fraction (LVEF) and high creatinine were independent predictors of the baseline ROCK activity in CHF. In terms of long-term heart failure mortality, ROCK activity was not an independent predictor. However, combining ROCK activity and NT-proBNP provided an incremental value in predicting long-term heart failure mortality over NT-proBNP alone. / Thus, increased ROCK activity is likely involved in cardiovascular diseases and further studies would be helpful to elucidate the potential role of ROCK activity inhibition in cardiovascular diseases. / We also recruited a group of 178 patients with CHF. All the patients were enrolled between December 2007 and January 2009 and followed up until 1st February 2010 (mean: 14.4+/-7.2 months, from 0.5 month to 26 months) or until the occurrence of cardiac death. Forty-five patients died (25.3%) within 2 years follow up. / Dong, Ming. / Adviser: Cheuk Man Yu. / Source: Dissertation Abstracts International, Volume: 73-04, Section: B, page: . / Thesis (Ph.D.)--Chinese University of Hong Kong, 2011. / Includes bibliographical references (leaves 140-164). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. [Ann Arbor, MI] : ProQuest Information and Learning, [201-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstract also in Chinese.

Notch signaling controls normal and pathological angiogenesis through transcriptional regulation of a wide network of target genes. Despite intensive studies of the endothelial Notch function, a comprehensive list of Notch-regulated genes, especially direct transcriptional targets, has not been assembled in endothelial cells (ECs). Here we uncovered novel EC Notch targets that are rapidly regulated by Notch signaling using several unbiased in vivo and in vitro screening approaches that captured genes regulated within 6 hours or less of Notch signal activation. We used a gamma-secretase inhibitor in neonates to profile Notch targets in the brain endothelium using the RiboTag technique, allowing for isolation of endothelial specific mRNA from a complex tissue without disrupting cell-cell contact. We used two types of primary cultured endothelial cells to define ligand-specific Notch targets by tethered-ligand stimulation. The identified Notch targets were validated by determining their regulation within one to two hours of EGTA-mediated Notch activation. By comparing significantly regulated genes in each of the screens, we assembled a comprehensive database of potential Notch targets in endothelial cells. Of particular interest, we uncovered G protein pathway related genes as potential novel Notch targets. We focused on a novel candidate target passing selection criteria after all screens, a small GTPase RND1. RND1(Rho GTPase1) regulates cytoskeleton arrangement through Rho and Ras signaling. RND1 was validated as an endothelial Notch target in multiple endothelial cell types. In Human Umbilical Vein Endothelial Cells (HUVECs) we established angiogenic activity for RND1 that included regulation of cell migration towards VEGF and function in sprouting angiogenesis. We established that Notch and RND1 suppressed Ras activation but had no effects on Rho activation in HUVECs. These results demonstrate that RND1 expression is regulated by Notch signaling in endothelium and suggest that RND1 functions downstream of Notch in sprouting angiogenesis, revealing an unexplored role of endothelial Notch in regulating G protein pathways.